PTC Therapeutics

PTC Therapeutics

Employees:
300
Market Cap:
$562.46 million
Revenue:
$82.85 million
5 Year Trend:
4.7%
Net Income:
$-130.44 million
NASDAQ:
PTCT

PTC Therapeutics is a US pharmaceutical company focused on the development of small molecule, orally administered treatments for orphan diseases. Since 2003, PTC has been working on a drug for Duchenne muscular dystrophy. Wikipedia

PTC Therapeutics

PTC Therapeutics is a US pharmaceutical company focused on the development of small molecule, orally administered treatments for orphan diseases. Since 2003, PTC has been working on a drug for Duchenne muscular dystrophy. Wikipedia

Employees:
300
Market Cap:
$562.46 million
Revenue:
$82.85 million
5 Year Trend:
4.7%
Net Income:
$-130.44 million
NASDAQ:
PTCT